The U.K. is the top pick for high school students, and the U.S. is most popular for undergrad and graduate studies
A presentation by Western States Petroleum Association, one of the most powerful oil and gas lobbies, details an elaborate plan to thwart California's move away from fossil fuels
Calorie counts may not persuade people to order healthy food, but they might prod restaurants into slimming down what's on the menu
Ricardo Reyes previously ran communications at Tesla until 2012
The Wall Street investment bank has a new measure of consumer spending power it says points to "ending the year on a strong note"
How to cope with a traveler's headache: a winter storm across the East Coast on a day when 46 million Americans hit the roads and airports
Graduate students get paid close to the minimum wage to do high-level coding work for tech companies
Few small businesses have a real, rational marketing budget. Here’s why that’s OK
Founder: Dr. John Hadden
VC Investment over the last four quarters: $25 million
IRX Therapeutics is a 40-employee biotech firm developing drugs to restore immune system function, particularly in patients with head and neck cancer. Founded over a decade ago and backed by more than $60 million raised mostly from high-net-worth individuals, the company has reduced headcount by a third and delayed some clinical trials planned for 2009, according to Chief Financial Officer Jeffrey Hwang.
Key to startup success: "In normal times where the capital is available, the difference maker among people with good ideas is sharp execution. There's never a substitute for the ability to attract and retain experienced, qualified people to take advantage of the discovery you've made."